Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells.

Tezcanli Kaymaz, Burcin; Selvi Gunel, Nur; Sogutlu, Fatma; Ozates Ay, Neslihan Pinar; Baran, Yusuf; Gunduz, Cumhur; Biray Avci, Cigir

Tezcanli Kaymaz, Burcin; Selvi Gunel, Nur; Sogutlu, Fatma; Ozates Ay, Neslihan Pinar; Baran, Yusuf; Gunduz, Cumhur; Biray Avci, Cigir.

Afiliación

Tezcanli Kaymaz B; Department of Medical Biology, Ege University Medicine Faculty, 35100, Izmir, Turkey.
Selvi Gunel N; Department of Medical Biology, Ege University Medicine Faculty, 35100, Izmir, Turkey.
Sogutlu F; Department of Medical Biology, Ege University Medicine Faculty, 35100, Izmir, Turkey.
Ozates Ay NP; Department of Medical Biology, Ege University Medicine Faculty, 35100, Izmir, Turkey.
Baran Y; Department of Molecular Biology and Genetics, Faculty of Science, Izmir Institute of Technology, 35433, Izmir, Turkey.
Gunduz C; Department of Medical Biology, Ege University Medicine Faculty, 35100, Izmir, Turkey.
Biray Avci C; Department of Medical Biology, Ege University Medicine Faculty, 35100, Izmir, Turkey.

Iran J Basic Med Sci ; 25(7): 904-912, 2022 Jul.

Article en En | MEDLINE | ID: mdl-36033954

Palabras clave

CML; Chemotherapeutic resistance; Energy metabolism; Nilotinib; RNAi-based therapeutics; STAT3; Tyrosine kinase inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Iran J Basic Med Sci Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google